🇺🇸 FDA
Patent

US 10501801

Identification of tumor-protective epitopes for the treatment of cancers

granted A61KA61K2039/55561A61K39/0011

Quick answer

US patent 10501801 (Identification of tumor-protective epitopes for the treatment of cancers) held by UNIVERSITY OF CONNECTICUT expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K2039/55561, A61K39/0011, A61P, A61P35/00